MTHFR and Hypertension: Suboptimal riboflavin status, as indicated by EGRac >1.26,25 was also associated with an increased risk of hypertension in the same model, OR: 1.97, 95% CI: 1.27–3.05, p = 0.002, independent of the MTHFR genotype.